Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 93 articles:
HTML format
Text format



Single Articles


    July 2017
  1. SOORYANARAIN H, Rogers AJ, Cao D, Haac MER, et al
    ISG15 modulates type-I interferon signaling and antiviral response during hepatitis E virus replication.
    J Virol. 2017 Jul 19. pii: JVI.00621-17. doi: 10.1128/JVI.00621.
    PubMed     Text format     Abstract available


  2. YIN P, Li Y, Zhang L
    Sec24C-Dependent Transport of Claudin-1 Regulates Hepatitis C Virus Entry.
    J Virol. 2017 Jul 5. pii: JVI.00629-17. doi: 10.1128/JVI.00629.
    PubMed     Text format     Abstract available


    June 2017
  3. WELLER R, Hueging K, Brown RJP, Todt D, et al
    Hepatitis C virus strain-dependent usage of apolipoprotein E modulates assembly efficiency and specific infectivity of secreted virions.
    J Virol. 2017 Jun 28. pii: JVI.00422-17. doi: 10.1128/JVI.00422.
    PubMed     Text format     Abstract available


  4. BELOUZARD S, Danneels A, Feneant L, Seron K, et al
    Entry and release of hepatitis C virus in polarized human hepatocytes.
    J Virol. 2017 Jun 28. pii: JVI.00478-17. doi: 10.1128/JVI.00478.
    PubMed     Text format     Abstract available


  5. CEVIK RE, Cesarec M, Da Silva Filipe A, Licastro D, et al
    Hepatitis C virus NS5A targets the nucleosome assembly protein NAP1L1 to control the innate cellular response.
    J Virol. 2017 Jun 28. pii: JVI.00880-17. doi: 10.1128/JVI.00880.
    PubMed     Text format     Abstract available


  6. LUO J, Cui X, Gao L, Hu J, et al
    Identification of Intermediate in Hepatitis B Virus CCC DNA Formation and Sensitive and Selective CCC DNA Detection.
    J Virol. 2017 Jun 21. pii: JVI.00539-17. doi: 10.1128/JVI.00539.
    PubMed     Text format     Abstract available


  7. GOONAWARDANE N, Gebhardt A, Bartlett C, Pichlmair A, et al
    Phosphorylation of serine 225 in hepatitis C virus NS5A regulates protein-protein interactions.
    J Virol. 2017 Jun 14. pii: JVI.00805-17. doi: 10.1128/JVI.00805.
    PubMed     Text format     Abstract available


    May 2017
  8. WONG MT, Chen SS
    Hepatitis C Virus Subverts Human Choline Kinase-alpha to Bridge PI4KIIIalpha and NS5A and Upregulates PI4KIIIalpha Activation, Thereby Promoting the Translocation of the Ternary Complex to the ER for Viral Replication.
    J Virol. 2017 May 31. pii: JVI.00355-17. doi: 10.1128/JVI.00355.
    PubMed     Text format     Abstract available


  9. WU S, Zhao Q, Zhang P, Kulp J, et al
    Discovery and mechanistic study of benzamide derivatives that modulate hepatitis B virus capsid assembly.
    J Virol. 2017 May 31. pii: JVI.00519-17. doi: 10.1128/JVI.00519.
    PubMed     Text format     Abstract available


  10. LI Z, Li Y, Bi Y, Zhang H, et al
    Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E.
    J Virol. 2017 May 24. pii: JVI.02227-16. doi: 10.1128/JVI.02227.
    PubMed     Text format     Abstract available


  11. SYED GH, Khan M, Yang S, Siddiqui A, et al
    Hepatitis C virus lipoviroparticles (HCV-LVP) assemble in the endoplasmic reticulum (ER) and bud off from the ER to Golgi in COPII vesicles.
    J Virol. 2017 May 17. pii: JVI.00499-17. doi: 10.1128/JVI.00499.
    PubMed     Text format     Abstract available


  12. DEVHARE PB, Sasaki R, Shrivastava S, Di Bisceglie AM, et al
    Correction for Devhare et al., "Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells".
    J Virol. 2017;91.
    PubMed     Text format    


    April 2017
  13. FILSKOV J, Mikkelsen M, Hansen PR, Christensen JP, et al
    Broadening CD4+ and CD8+ T cell responses against hepatitis C virus by vaccination with NS3 overlapping peptide panels in cross-priming liposomes.
    J Virol. 2017 Apr 26. pii: JVI.00130-17. doi: 10.1128/JVI.00130.
    PubMed     Text format     Abstract available


  14. HSU SC, Lo CW, Pan TC, Lee KY, et al
    Serine 235 Is the Primary NS5A Hyper-Phosphorylation Site Responsible for HCV Replication.
    J Virol. 2017 Apr 26. pii: JVI.00194-17. doi: 10.1128/JVI.00194.
    PubMed     Text format     Abstract available


  15. FAN H, Qiao L, Kang KD, Fan J, et al
    Attachment and Post-Attachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission.
    J Virol. 2017 Apr 12. pii: JVI.00280-17. doi: 10.1128/JVI.00280.
    PubMed     Text format     Abstract available


    March 2017
  16. MORENO E, Gallego I, Gregori J, Lucia-Sanz A, et al
    Internal disequilibria and phenotypic diversification during replication of hepatitis C virus in a non-coevolving cellular environment.
    J Virol. 2017 Mar 8. pii: JVI.02505-16. doi: 10.1128/JVI.02505.
    PubMed     Text format     Abstract available


  17. OJIRO K, Qu X, Cho H, Park JJ, et al
    Modulation of HCV-specific CD8 effector T-cell function with antiviral effect in infectious hepatitis C virus co-culture model.
    J Virol. 2017 Mar 8. pii: JVI.02129-16. doi: 10.1128/JVI.02129.
    PubMed     Text format     Abstract available


    February 2017
  18. BALASIDDAIAH A, Davanian H, Aleman S, Pasetto A, et al
    Hepatitis C Virus-Specific T Cell Receptor mRNA-engineered Human T Cells: Impact of Antigen-Specificity on Functional Properties.
    J Virol. 2017 Feb 22. pii: JVI.00010-17. doi: 10.1128/JVI.00010.
    PubMed     Text format     Abstract available


  19. BRAYNE AB, Dearlove BL, Lester JS, Kosakovsky Pond SL, et al
    Genotype-specific evolution of hepatitis E virus.
    J Virol. 2017 Feb 15. pii: JVI.02241-16. doi: 10.1128/JVI.02241.
    PubMed     Text format     Abstract available


  20. HADDAD J, Rouille Y, Hanoulle X, Descamps V, et al
    Identification of novel functions for hepatitis C virus envelope glycoprotein E1 in virus entry and assembly.
    J Virol. 2017 Feb 8. pii: JVI.00048-17. doi: 10.1128/JVI.00048.
    PubMed     Text format     Abstract available


  21. FREEDMAN H, Logan MR, Hockman D, Leman JK, et al
    Computational prediction of the heterodimeric and higher order structure of gpE1/gpE2 envelope glycoproteins encoded by the hepatitis C virus (HCV).
    J Virol. 2017 Feb 1. pii: JVI.02309-16. doi: 10.1128/JVI.02309.
    PubMed     Text format     Abstract available


  22. YANG X, Li H, Sun H, Fan H, et al
    Hepatitis B virus-encoded miRNA controls viral replication.
    J Virol. 2017 Feb 1. pii: JVI.01919-16. doi: 10.1128/JVI.01919.
    PubMed     Text format     Abstract available


    January 2017
  23. CHEN J, Xu W, Chen Y, Xie X, et al
    MMP-9 Facilitates Hepatitis B Virus Replication through Binding with IFNAR1 to Repress IFN/JAK/STAT Signaling.
    J Virol. 2017 Jan 25. pii: JVI.01824-16. doi: 10.1128/JVI.01824.
    PubMed     Text format     Abstract available


  24. TONG Y, Chi X, Yang W, Zhong J, et al
    Functional analysis of HCV envelope protein E1 using a trans-complementation system reveals a dual role of a putative fusion peptide of E1 in both HCV entry and morphogenesis.
    J Virol. 2017 Jan 18. pii: JVI.02468-16. doi: 10.1128/JVI.02468.
    PubMed     Text format     Abstract available


  25. DEVHARE PB, Sasaki R, Shrivastava S, Di Bisceglie AM, et al
    Exosome mediated intercellular communication between hepatitis C virus infected hepatocytes and hepatic stellate cells.
    J Virol. 2017 Jan 11. pii: JVI.02225-16. doi: 10.1128/JVI.02225.
    PubMed     Text format     Abstract available


  26. HO CK, Raghwani J, Koekkoek S, Liang RH, et al
    Characterization of HCV envelope diversification from acute to chronic infection using SMRT sequencing within a sexually-transmitted hepatitis C virus cluster.
    J Virol. 2017 Jan 11. pii: JVI.02262-16. doi: 10.1128/JVI.02262.
    PubMed     Text format     Abstract available


  27. YAN Y, He Y, Boson B, Wang X, et al
    A point mutation in the N-terminal amphiphathic helix alpha0 in NS3 promotes HCV assembly by altering core localization to ER and facilitating virus budding.
    J Virol. 2017 Jan 4. pii: JVI.02399-16. doi: 10.1128/JVI.02399.
    PubMed     Text format     Abstract available


  28. WALTER S, Rasche A, Moreira-Soto A, Pfaender S, et al
    Differential Infection Patterns and Recent Evolutionary Origins of Equine Hepaciviruses in Donkeys.
    J Virol. 2016;91.
    PubMed     Text format     Abstract available


    December 2016
  29. MCCAFFREY K, Boo I, Owczarek CM, Hardy MP, et al
    An optimized hepatitis C virus E2 glycoprotein core adopts a functional homodimer that efficiently blocks virus entry.
    J Virol. 2016 Dec 28. pii: JVI.01668-16. doi: 10.1128/JVI.01668.
    PubMed     Text format     Abstract available


  30. DING Q, von Schaewen M, Hrebikova G, Heller B, et al
    Mice expressing minimally humanized CD81 and occludin genes support hepatitis C virus uptake in vivo.
    J Virol. 2016 Dec 7. pii: JVI.01799.
    PubMed     Text format     Abstract available


  31. MURAYAMA A, Sugiyama N, Suzuki R, Moriyama M, et al
    Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
    J Virol. 2016 Dec 7. pii: JVI.02124.
    PubMed     Text format     Abstract available


    November 2016
  32. CLARK DN, Flanagan JM, Hu J
    Mapping of Functional Subdomains in Terminal Protein Domain of Hepatitis B Virus Polymerase.
    J Virol. 2016 Nov 16. pii: JVI.01785.
    PubMed     Text format     Abstract available


  33. PHAM TM, Tran SC, Lim YS, Hwang SB, et al
    Hepatitis C Virus-Induced Rab32 Aggregation and its Implication in Virion Assembly.
    J Virol. 2016 Nov 16. pii: JVI.01662.
    PubMed     Text format     Abstract available


  34. ZHAO F, Zhao T, Deng L, Lv D, et al
    Visualizing the essential role of complete virion assembly machinery in efficient hepatitis C virus cell-to-cell transmission by viral infection activated split-intein mediated reporter system (VISI).
    J Virol. 2016 Nov 16. pii: JVI.01720.
    PubMed     Text format     Abstract available


  35. PIETSCHMANN T
    Clinically approved ion channel inhibitors close gates for hepatitis C virus -and open doors for drug repurposing in viral infectious diseases.
    J Virol. 2016 Nov 2. pii: JVI.01914.
    PubMed     Text format     Abstract available


  36. WANG J, Qiao L, Hou Z, Luo G, et al
    TIM-1 promotes hepatitis C virus cell attachment and infection.
    J Virol. 2016 Nov 2. pii: JVI.01583.
    PubMed     Text format     Abstract available


    October 2016
  37. LOGAN M, Law J, Wong JA, Hockman D, et al
    Native folding of a recombinant gpE1/gpE2 heterodimer vaccine antigen from a precursor protein fused with Fc IgG.
    J Virol. 2016 Oct 19. pii: JVI.01552.
    PubMed     Text format     Abstract available


  38. ELGNER F, Ren H, Medvedev R, Ploen D, et al
    The intra-cellular cholesterol transport inhibitor U18666A inhibits the exosome-dependent release of mature hepatitis C virus.
    J Virol. 2016 Oct 5. pii: JVI.01053.
    PubMed     Text format     Abstract available


    September 2016
  39. CHAN ST, Lee J, Narula M, Ou JJ, et al
    Suppression of Host Innate Immune Response by Hepatitis C Virus via the Induction of Autophagic Degradation of TRAF6.
    J Virol. 2016 Sep 28. pii: JVI.01365.
    PubMed     Text format     Abstract available


  40. BAYER K, Banning C, Bruss V, Wiltzer-Bach L, et al
    Hepatitis C virus is released via a non-canonical secretory route.
    J Virol. 2016 Sep 14. pii: JVI.01615.
    PubMed     Text format     Abstract available


  41. LI D, von Schaewen M, Wang X, Tao W, et al
    Altered glycosylation patterns increase immunogenicity of a subunit HCV vaccine inducing neutralizing antibodies which confer protection in mice.
    J Virol. 2016 Sep 14. pii: JVI.01462.
    PubMed     Text format     Abstract available


  42. ZUIANI A, Chen K, Schwarz MC, White JP, et al
    An E2 gene infectious HCV library reveals growth adaptive mutations that modulate interactions with the scavenger receptor class B type I.
    J Virol. 2016 Sep 14. pii: JVI.01011.
    PubMed     Text format     Abstract available


    August 2016
  43. YI Z, Fang C, Zou J, Xu J, et al
    Affinity purification of the Hepatitis C virus replicase identifies Valosin-containing protein (VCP) AAA+ATPase as an active viral replication modulator.
    J Virol. 2016 Aug 24. pii: JVI.01140.
    PubMed     Text format     Abstract available


  44. YANG Z, Wang X, Chi X, Zhao F, et al
    Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection.
    J Virol. 2016 Aug 17. pii: JVI.01353.
    PubMed     Text format     Abstract available


  45. KIM W, Lee S, Son Y, Ko C, et al
    DDB1 stimulates the viral transcription of hepatitis B virus via HBx-independent mechanisms.
    J Virol. 2016 Aug 17. pii: JVI.00977.
    PubMed     Text format     Abstract available


  46. SOZZI V, Walsh R, Littlejohn M, Colledge D, et al
    In vitro studies show that sequence variability contributes to marked variation in Hepatitis B virus replication, protein expression and function observed across genotypes.
    J Virol. 2016 Aug 10. pii: JVI.01293.
    PubMed     Text format     Abstract available


  47. WONG MT, Chen SS
    Human Choline Kinase-alpha Promotes Hepatitis C Virus RNA Replication through Modulating Membranous Viral Replication Complex Formation.
    J Virol. 2016 Aug 3. pii: JVI.00960.
    PubMed     Text format     Abstract available


  48. NAKAJIMA S, Watashi K, Ohashi H, Kamisuki S, et al
    Fungal-derived neoechinulin B as a novel antagonist of liver X receptor, identified by chemical genetics using hepatitis C virus cell culture system.
    J Virol. 2016 Aug 3. pii: JVI.00856.
    PubMed     Text format     Abstract available


  49. BLEAU C, Filliol A, Samson M, Lamontagne L, et al
    MOUSE HEPATITIS VIRUS INFECTION INDUCES A TLR2-DEPENDENT ACTIVATION OF INFLAMMATORY FUNCTIONS IN LIVER SINUSOIDAL ENDOTHELIAL CELLS DURING ACUTE HEPATITIS.
    J Virol. 2016 Aug 3. pii: JVI.01069.
    PubMed     Text format     Abstract available


    July 2016
  50. HE W, Cao Z, Mao F, Ren B, et al
    Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.
    J Virol. 2016 Jul 27. pii: JVI.00901.
    PubMed     Text format     Abstract available


  51. PUIG-BASAGOITI F, Fukuhara T, Tamura T, Ono C, et al
    Human cathelicidin compensates for the role of apolipoproteins in the infectious particle formation of HCV.
    J Virol. 2016 Jul 20. pii: JVI.00471.
    PubMed     Text format     Abstract available


  52. UNCHWANIWALA N, Sherer NM, Loeb DD
    Hepatitis B virus polymerase localizes to the mitochondria and its terminal protein domain contains the mitochondrial-targeting signal.
    J Virol. 2016 Jul 20. pii: JVI.01229.
    PubMed     Text format     Abstract available


  53. DI SCALA M, Otano I, Gil-Farina I, Vanrell L, et al
    Complementary effects of IL-15 and IFN-alpha induce immunity in HBV transgenic mice.
    J Virol. 2016 Jul 20. pii: JVI.01030.
    PubMed     Text format     Abstract available


  54. VAUSSELIN T, Seron K, Lavie M, Mesalam AA, et al
    Identification of a new benzimidazole derivative as an antiviral against hepatitis C virus.
    J Virol. 2016 Jul 13. pii: JVI.00404.
    PubMed     Text format     Abstract available


  55. LI J, Zong L, Sureau C, Barker L, et al
    UNUSUAL FEATURES OF SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE AS A HEPATITIS B VIRUS RECEPTOR.
    J Virol. 2016 Jul 6. pii: JVI.01153.
    PubMed     Text format     Abstract available


  56. ZHU S, Li T, Liu B, Xu Y, et al
    Infection of common marmosets with GB virus B chimeric virus encoding for the major nonstructural proteins NS2-4A of hepatitis C virus.
    J Virol. 2016 Jul 6. pii: JVI.02653.
    PubMed     Text format     Abstract available


    June 2016
  57. COLMAN H, Berre-Scoul CL, Hernandez C, Pierredon S, et al
    Correction for Colman et al., Genome-Wide Analysis of Host mRNA Translation during Hepatitis C Virus Infection.
    J Virol. 2016;90:5846.
    PubMed     Text format    


  58. MACPARLAND SA, Ma XZ, Chen L, Khattar R, et al
    Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.
    J Virol. 2016;90:5549-60.
    PubMed     Text format     Abstract available


  59. COWTON VM, Angus AG, Cole SJ, Markopoulou CK, et al
    Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.
    J Virol. 2016 Jun 8. pii: JVI.00685.
    PubMed     Text format     Abstract available


  60. BISWAS A, Treadaway J, Tellinghuisen TL
    Interaction Between Non-Structural Proteins NS4B And NS5A Is Essential For Proper NS5A Localization And Hepatitis C Virus RNA Replication.
    J Virol. 2016 Jun 1. pii: JVI.00037.
    PubMed     Text format     Abstract available


  61. TRAN SC, Pham TM, Nguyen LN, Park EM, et al
    Nonstructural 3 protein of hepatitis C virus modulates tribbles homolog 3/Akt signaling pathway for persistent viral infection.
    J Virol. 2016 Jun 1. pii: JVI.00326.
    PubMed     Text format     Abstract available


  62. BETZ-STABLEIN BD, Topfer A, Littlejohn M, Yuen L, et al
    Single-molecule sequencing reveals complex genomic variation of hepatitis B virus during 15 years of chronic infection following liver transplantation.
    J Virol. 2016 Jun 1. pii: JVI.00243.
    PubMed     Text format     Abstract available


    May 2016
  63. MANKOURI J, Walter C, Stewart H, Bentham M, et al
    Release of infectious hepatitis C virus from Huh7 cells occurs via a trans-Golgi network to endosome pathway independent of VLDL.
    J Virol. 2016 May 25. pii: JVI.00826.
    PubMed     Text format     Abstract available


  64. XUE B, Yang D, Wang J, Xu Y, et al
    ISG12a restricts hepatitis C virus infection through ubiquitination-dependent degradation pathway.
    J Virol. 2016 May 18. pii: JVI.00352.
    PubMed     Text format     Abstract available


  65. BANDIERA S, Pernot S, El Saghire H, Durand SC, et al
    HCV-induced up-regulation of miR-146a-5p in hepatocytes promotes viral infection and deregulates metabolic pathways associated with liver disease pathogenesis.
    J Virol. 2016 May 4. pii: JVI.00619.
    PubMed     Text format     Abstract available


    April 2016
  66. VAN MONTFOORT N, van der Aa E, van den Bosch A, Brouwers H, et al
    Hepatitis B surface antigen activates myeloid dendritic cells via a soluble CD14-dependent mechanism.
    J Virol. 2016 Apr 20. pii: JVI.02903.
    PubMed     Text format     Abstract available


  67. VEGNA S, Gregoire D, Moreau M, Lassus P, et al
    NOD1 participates in the innate immune response triggered by the hepatitis C viral polymerase.
    J Virol. 2016 Apr 20. pii: JVI.03230.
    PubMed     Text format     Abstract available


  68. REN H, Elgner F, Jiang B, Himmelsbach K, et al
    The autophagosomal SNARE protein syntaxin 17 is an essential factor for the hepatitis C virus life cycle.
    J Virol. 2016 Apr 20. pii: JVI.00551.
    PubMed     Text format     Abstract available


  69. LUDGATE L, Liu K, Luckenbaugh L, Streck N, et al
    Cell-free Hepatitis B Virus Capsid Assembly Dependent on Core Protein C-Terminal Domain and Regulated by Phosphorylation.
    J Virol. 2016 Apr 13. pii: JVI.00394.
    PubMed     Text format     Abstract available


  70. KOUWAKI T, Okamoto T, Ito A, Sugiyama Y, et al
    Hepatocyte Factor JMJD5 Regulates Hepatitis B Virus Replication through Interaction with HBx.
    J Virol. 2016;90:3530-42.
    PubMed     Text format     Abstract available


    March 2016
  71. BIEGEL JM, Pager CT
    Hepatitis C Virus Exploitation of Processing Bodies.
    J Virol. 2016 Mar 2. pii: JVI.03056.
    PubMed     Text format     Abstract available


    February 2016
  72. SWANN RE, Cowton VM, Robinson MW, Cole SJ, et al
    Broad anti-HCV antibody responses are associated with improved clinical disease parameters in chronic HCV infection.
    J Virol. 2016 Feb 24. pii: JVI.02669.
    PubMed     Text format     Abstract available


  73. VAN DE GARDE MD, Pas SD, van der Net G, de Man RA, et al
    Hepatitis E virus genotype three infection of human liver chimeric mice as a model for chronic HEV infection.
    J Virol. 2016 Feb 17. pii: JVI.00114.
    PubMed     Text format     Abstract available


  74. LEE EM, Alsagheir A, Wu X, Hammack C, et al
    Hepatitis C virus induced degradation of cell death-inducing DFFA-like effector B leads to hepatic lipid dysregulation.
    J Virol. 2016 Feb 10. pii: JVI.02891.
    PubMed     Text format     Abstract available


  75. LEMPP FA, Qu B, Wang YX, Urban S, et al
    Hepatitis B Virus infection of a mouse hepatic cell line reconstituted with human sodium taurocholate cotransporting polypeptide.
    J Virol. 2016 Feb 10. pii: JVI.02832.
    PubMed     Text format     Abstract available


  76. YIN X, Ambardekar C, Lu Y, Feng Z, et al
    Distinct entry mechanisms for non-enveloped and quasi-enveloped hepatitis E virus.
    J Virol. 2016 Feb 10. pii: JVI.02804.
    PubMed     Text format     Abstract available


  77. VENKATAKRISHNAN B, Katen SP, Francis S, Chirapu S, et al
    Hepatitis B virus capsids have diverse structural responses to small molecule ligands bound to the HAP pocket.
    J Virol. 2016 Feb 3. pii: JVI.03058.
    PubMed     Text format     Abstract available


    January 2016
  78. WASILEWSKI LN, El-Diwany R, Munshaw S, Snider AE, et al
    A hepatitis C virus envelope polymorphism confers resistance to neutralization by polyclonal sera and broadly neutralizing monoclonal antibodies.
    J Virol. 2016 Jan 27. pii: JVI.02837.
    PubMed     Text format     Abstract available


  79. SANDOMENICO A, Leonardi A, Berisio R, Sanguigno L, et al
    Generation and characterization of monoclonal antibodies against a cyclic variant of Hepatitis C Virus E2 epitope 412-422.
    J Virol. 2016 Jan 27. pii: JVI.02397.
    PubMed     Text format     Abstract available


  80. KONG L, Fujimoto A, Nakamura M, Aoyagi H, et al
    Prolactin regulatory element binding protein is involved in hepatitis C virus replication compartment by interacting with NS4B.
    J Virol. 2016 Jan 6. pii: JVI.01540.
    PubMed     Text format     Abstract available


  81. KECK ZY, Girard-Blanc C, Wang W, Lau P, et al
    Antibody response to the hypervariable region-1 interferes with broadly neutralizing antibodies to hepatitis C virus.
    J Virol. 2016 Jan 6. pii: JVI.02458.
    PubMed     Text format     Abstract available


    December 2015
  82. JIANG B, Himmelsbach K, Ren H, Boller K, et al
    Subviral hepatitis B virus filaments are released like infectious viral particles via multivesicular bodies.
    J Virol. 2015 Dec 30. pii: JVI.03109.
    PubMed     Text format     Abstract available


  83. PALMER BA, Schmidt-Martin D, Dimitrova Z, Skums P, et al
    Network analysis of the chronic Hepatitis C virome defines HVR1 evolutionary phenotypes in the context of humoral immune responses.
    J Virol. 2015 Dec 30. pii: JVI.02995.
    PubMed     Text format     Abstract available


  84. GOMES R, Isken O, Tautz N, McLauchlan J, et al
    Polyprotein driven formation of two interdependent sets of complexes supporting hepatitis C virus genome replication.
    J Virol. 2015 Dec 30. pii: JVI.01931.
    PubMed     Text format     Abstract available


  85. TRAN GV, Luong TT, Park EM, Kim JW, et al
    Nonstructural 5A Protein of Hepatitis C Virus Regulates Soluble Resistance-related Calcium-binding Protein Activity for Viral Propagation.
    J Virol. 2015 Dec 30. pii: JVI.02493.
    PubMed     Text format     Abstract available


  86. JEE MH, Hong KY, Park JH, Lee JS, et al
    A new mechanism of hepatic fibrogenesis: hepatitis C virus infection induces TGF-beta1 production through glucose-regulated protein 94.
    J Virol. 2015 Dec 30. pii: JVI.02976.
    PubMed     Text format     Abstract available


  87. URBANOWICZ RA, McClure CP, Brown RJ, Tsoleridis T, et al
    A diverse panel of Hepatitis C Virus glycoproteins for use in vaccine research reveals extremes of monoclonal antibody neutralization resistance.
    J Virol. 2015 Dec 23. pii: JVI.02700.
    PubMed     Text format     Abstract available


  88. BASU R, Banerjee K, Bose A, Das Sarma J, et al
    Mouse Hepatitis Virus infection remodels Connexin43 mediated gap junction intercellular communication both in vitro and in vivo.
    J Virol. 2015 Dec 16. pii: JVI.02420.
    PubMed     Text format     Abstract available


  89. YU R, Yang D, Lei S, Wang X, et al
    HMGB1 promotes hepatitis C virus replication by interaction with the stem-loop 4 in viral 5' untranslated region.
    J Virol. 2015 Dec 9. pii: JVI.02795.
    PubMed     Text format     Abstract available


  90. ELSEBAI MF, Koutsoudakis G, Saludes V, Perez-Vilaro G, et al
    Pan-genotypic hepatitis C virus inhibition by natural products derived from the wild Egyptian artichoke.
    J Virol. 2015 Dec 9. pii: JVI.02030.
    PubMed     Text format     Abstract available


  91. WU YL, Peng XE, Zhu YB, Yan XL, et al
    Hepatitis B virus X protein induces hepatic steatosis by enhancing the expression of liver fatty acid binding protein.
    J Virol. 2015 Dec 4. pii: JVI.02604.
    PubMed     Text format     Abstract available


    November 2015
  92. SHRIVASTAVA S, Devhare P, Sujijantarat N, Steele R, et al
    Knockdown of autophagy inhibits infectious hepatitis C virus release by exosomal pathway.
    J Virol. 2015 Nov 18. pii: JVI.02383.
    PubMed     Text format     Abstract available


    October 2015
  93. UCHIDA T, Hiraga N, Imamura M, Tsuge M, et al
    Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice.
    J Virol. 2015;89:10087-96.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: